The CO-specific heme-based sensor CooA regulates the ability of Rhodospirillum rubrum to grow on CO as an energy source. Only CO triggers the conformational change of CooA essential for the protein to function as a transcriptional activator. A structurally informed mutagenesis, followed by an in vivo screening method, allowed the isolation of a series of novel CooA variants that show very substantial response to imidazole. Compared with wild-type CooA, the ligand selectivity between imidazole and CO had been changed in some variants by roughly three orders of magnitude. Remarkably, different CooA variants also showed the ability to discriminate among imidazole derivatives, strongly implying a mechanism of precise interactions between the affected residues and the various ligands. Although wild-type CooA and imidazole-responsive CooA variants appear to recognize their respective ligands by fundamentally different mechanisms, several lines of evidence suggest that they respond by a similar C-helix repositioning that results in the rearrangement of the DNA-binding domains responsible for specific DNA contact. These results have implications for the molecular basis of both the imidazole responsiveness in the variants and the stringent CO specificity of wild-type CooA.
Proteins that sense small gaseous molecules such as NO, O 2 , and CO play important roles in biological systems ranging from prokaryotes to mammals. In mammals, heme-containing soluble guanylyl cyclase serves a pivotal role for sensing NO (1) and possibly CO (2) . Several other sensors respond to O 2 , including the heme-based FixL and DOS proteins (3, 4) . These sensors use heme prosthetic groups to perceive the presence of different small molecules, but they show relatively less selectivity than does CooA 1 (5) . For example, hemoglobin is poised to discriminate against CO, but CO is still a potent inhibitor of O 2 transport. Although FixL shows significant discrimination for O 2 by some in vitro assays, it does respond to a variety of small molecules to some detectable extent (6) . In contrast, CooA, the CO-oxidation activator protein from Rhodospirillum rubrum, is highly selective toward CO and fails to respond detectably to other small molecules (7, 8) .
CooA is a heme-containing homodimeric transcriptional regulator that activates the genes required for the oxidation of CO only when CO binds to its heme groups (9 -11) . CooA exists in at least two general conformations: in the active conformation, the DNA-binding domains are positioned to allow the F helices to contact specific DNA targets, but in inactive conformations, these DNA-binding domains are positioned substantially differently (11) . Although these two conformations exist in equilibrium, CO binding, which displaces a subunit-swapped Nterminal Pro 2 ligand (12) , causes a shift in that equilibrium toward the active form. Structural analysis and additional experimentation have shown that the signal transduction mechanism between the CO-bound heme and the DNA-binding domains involves the repositioning about the C helices at the dimer interface (13, 14) . Importantly, a portion of these C helices also forms the distal heme pocket of CooA (Fig. 1 ). In the CO-bound form, the C-helix residues Ile 113 , Leu 116 , and Gly 117 have been identified to be near the bound CO by resonance Raman analysis (15) , and the roles of these residues in CooA function in response to CO have been evaluated (8, 16) . However, the active form of CooA has not been solved structurally and therefore the molecular basis of CO specificity is unknown. It has been shown that hydrophobicity along this region of the C helices is important for activity, leading to the notion that CO binding displaces the N terminus, which in turn exposes a hydrophobic surface of the C helices. This might provide the driving force for repositioning these C helices (8) . A central problem in understanding CooA function is therefore to explain the extreme CO specificity in terms of the mechanism that repositions the C helices. In other words, by what mechanism does the exclusive binding of CO to CooA stimulate this repositioning?
To better understand this process, we sought to perturb that selectivity by identifying CooA variants that functionally recognized another ligand. We used structural and spectroscopic information to identify residues near the bound CO, simultaneously randomized those residues to obtain a library of altered proteins, and then carried out a biological screen for CooA variants that respond to imidazole, a small molecule to which wild-type CooA is completely unresponsive. The subsequent biochemical characterization of these variants has revealed the basis of the response to imidazole and has important implications for the selectivity and responsiveness of wild-type CooA to CO.
EXPERIMENTAL PROCEDURES
Strains and Plasmids-The construction of strains overexpressing wild-type CooA and CooA variants in an Escherichia coli background having a ␤-galactosidase reporter system in the chromosome was described previously (17) . CooA variants were constructed in a pEXT20-based expression plasmid that provides tight control of cooA expression (18) .
Creation and Screening of cooA Mutations-Site-directed mutagenesis involved PCR amplification of cooA with primers designed to incorporate the desired nucleotide change, as described elsewhere (18) . The method used for codon randomization was essentially identical to the method used for site-directed mutagenesis, except that the primers contained randomized codons for targeted positions of cooA. CooA variants were screened for their ability to cause ␤-galactosidase accumulation in colonies incubated under different growth conditions as described previously (18) . 25 mM imidazole was used for the in vivo screening of imidazole-responsive variants; above 25 mM, the cell growth was severely inhibited. CooA variants were chosen based on colony color, and ␤-galactosidase activity was then determined quantitatively in liquid culture (18) , after which the cooA genes were sequenced to determine the causative residue changes. For biochemical characterization, wild-type, ⌬P3R4 (lacking Pro 3 and Arg 4 ) and selected imidazole-responsive CooA variants were his-tagged at the C terminus, expressed with 0.5 mM isopropyl 1-thio-␤-D-galactopyranoside, and purified as described below.
Purification of His-tagged Wild-type CooA and CooA Variants-The His-tagged wild-type CooA and CooA variants were purified with a Novagen nickel-nitrilotriacetic acid column. Although the purity was Ͼ95% after that step, we carried out an additional hydroxylapatite column to completely remove imidazole, then precipitated the purified proteins with a final concentration of 42.5% ammonium sulfate, and stored the proteins at Ϫ80°C. The heme content and extinction coefficient of CooA of each preparation were calculated using an extinction coefficient of 34.4 mM Ϫ1 cm Ϫ1 at 557 nm for the pyridine hemochrome (19) .
Production of Imidazole-, CO-, NO-, and CN
Ϫ -bound Forms-Imidazole-, 1-methylimidazole-, 4-methylimidazole-, CN Ϫ -, and CO-bound Fe(II) forms of various CooA proteins were generated by aerobic addition of each effector (50 mM KCN, 50 mM imidazole and its derivatives, and 20% CO (v/v)), followed by anaerobic addition of sodium dithionite to 2 mM. As stock solutions, 2.5 M imidazole, and its derivatives, and 2.5 M KCN were freshly prepared in 100 mM Tris-HCl, pH 8, 0.5 M KCl. The pH of the imidazole stock solution was re-adjusted to pH 8. For the production of NO-bound Fe(II) CooA, cuvettes or tubes (which were used for fluorescence polarization measurements) containing the Fe(III) forms were thoroughly degassed, 20% NO (v/v) gas was added, and then sodium dithionite was added to 2 mM. Imidazole, 1-methylimidazole, 2-methylimidazole, 4-methylimidazole, KCN, and sodium dithionite were purchased from Sigma or Aldrich.
UV-visible Absorption Spectroscopy-UV-visible absorption spectroscopy of CooA samples was performed at room temperature in quartz cuvettes using a Shimadzu UV-2401PC spectrophotometer. All the spectra were measured in 20 mM Tris-HCl, pH 8, 0.5 M KCl.
In Vivo Activity Assays and in Vitro DNA-binding Assays-In vivo activities of wild-type CooA and CooA variants were measured using an E. coli strain containing a chromosomally encoded ␤-galactosidase reporter system (18) and quantified using the standard protocol (20) . In vitro DNA-binding assays of CooA were performed by fluorescence polarization measured with a Beacon 2000 fluorescence polarization detector (PanVera Corp., Madison, WI) as described previously (18) . The binding mixture contained 40 mM Tris-HCl, pH 8.0, 6 mM CaCl 2 , 50 mM KCl, 5% glycerol (v/v), and 5 mM dithiothreitol. As a fluorescence probe, a 26-bp target DNA (pCooF) was labeled with Texas Red on one end of the duplex and used at the concentration of 6.4 nM. Salmon sperm DNA at 6.4 M was included in the reaction mixture to eliminate possible nonspecific DNA binding. Dissociation constants (K d ) were calculated by fitting the binding data to an equation that corrected fluorescence quenching as described elsewhere (21) .
RESULTS
In Vivo Screening and Identification of Novel Imidazoleresponsive CooA Variants-To better understand the specificity and response of wild-type CooA to CO, we sought CooA variants that could respond to a completely different effector, imidazole. We reasoned that a comparison of the similarities and differences between wild-type CooA and such variants would clarify the recognition processes in each.
Imidazole cannot bind to wild-type CooA, because it is unable to displace either heme ligand. In seeking imidazole-responsive variants, we therefore started with ⌬P3R4 CooA in which the codons for Pro 3 and Arg 4 have been deleted (8) . This weakens the Pro 2 ligand and therefore allows the binding of imidazole to the same side of the heme as is bound by CO when activating wild-type CooA. This variant is still not activated in response to imidazole binding (Ref. 8 and see below), which demonstrates that there is another level of ligand selectivity in CooA. In the ⌬P3R4 CooA background, we altered residues known to be near the bound CO in wild-type CooA (15) in the expectation that different residues might support a responsiveness to imidazole. We simultaneously randomized the codons for residues 113 and 116 and separately randomized the codons for positions 117 and 120 as well. E. coli cultures with libraries of mutagenized cooA alleles were screened for those that produced active CooA in the anaerobic presence of imidazole, based on detection of CooA-dependent ␤-galactosidase activity. Randomized libraries of positions 117 and 120 gave no positive clones, but at positions 113/116, ϳ2.5% of the 6400 colonies displayed intense blue color. After eliminating effector-independent variants, the cooA genes of selected clones were sequenced.
Twelve sequenced non-identical imidazole-responsive CooA variants (termed "Blue" in Table I ) displayed a range of responses to imidazole in a quantitative in vivo ␤-galactosidase assay, whereas wild-type and ⌬P3R4 CooA showed no response ( Table I ). The imidazole-responsive CooA variants also responded to CO to varying degrees. The striking pattern among imidazole-responsive CooA variants with high activity is the presence of a Trp residue at either position 113 or 116, although a Trp residue at position 116 tended to severely perturb CO-responsive activity (Table I ). In addition to the requirement Two monomers, shaded differently in this figure, dimerize along the central C-helices (␣ C ) adjacent to the heme prosthetic group. Although the solved structure is asymmetrical, both DNA-binding F-helices (␣ F ) are buried from solvent, implying that a dramatic conformational change must occur upon activation to allow both F-helices to make specific DNA contacts. The heme-binding region of the protein is enlarged on the right side along with the residues noted in this study. The asterisk indicates an amino acid residue from the other subunit. The figure was generated using Swiss-PdbViewer 3.7.
for a Trp residue, there are obviously effects of the other residues as well: half of the Blue variants possess Trp at position 113, but show an imidazole response of 5.7-117%, depending on the residue at position 116. These differences presumably reflect effects on in vivo activity such as the accumulation level of heme-containing CooA proteins, their affinity for imidazole, their interactions with an RNA polymerase, and the degree to which imidazole binding stimulates the equilibrium shift to the active form. In fact, lowering the external imidazole concentration by 2.5-fold decreased the activities of imidazole-responsive variants, suggesting that even 25 mM imidazole in the growth medium may not be a saturating condition (data not shown Table I ). The in vitro quantification of the dramatic alteration in ligand specificity is described below. The efficacy of Trp residues, compared with that of Phe and Tyr, suggests that its particular geometry is important.
Binding of Imidazole to the Heme Affords DNA Binding in Selected Imidazole-responsive CooA Variants-To show that the imidazole-responsive activity in vivo correlates with the transition of CooA to the DNA-binding form, we carried out in vitro biochemical analysis with purified imidazole-responsive variants. For this analysis, selected imidazole-responsive variants, together with wild-type and ⌬P3R4 CooA, were Histagged and purified as described under "Experimental Procedures." As shown in Fig. 2A , all the tested CooA variants, including ⌬P3R4 CooA, had a significant population of fivecoordinate species in their Fe(II) forms, as indicated by the elevated ⑀ Fe(II)ϩCO /⑀ Fe(II) ratio of Soret maxima, which range from 1.08 for wild-type CooA to more than 1.7 for several variants (see "⑀ Fe(II)ϩCO /⑀ Fe(II) " column in Table II ). Based on the titration of imidazole binding, all CooA variants were saturated in the presence of 50 mM imidazole, and their spectra appear to be fully of six coordinates ( Fig. 2A ; see also the "⑀ Fe(II)ϩCO /⑀ Fe(II)ϩImi " column in Table II) . We assume that imidazole binds to the five-coordinate species created by the weakened Pro 2 ligation and shifts the equilibrium to the sixcoordinate imidazole adducts. The approximate K d values for imidazole binding to the Fe(II) forms of the variants ranged from 0.1 to 5 mM (data not shown). These affinities are within an order of magnitude of the imidazole affinity of N-terminalacetylated microperoxidase-8, whose Fe(II) form is known to be five coordinate (22) , consistent with the model for imidazole binding by these CooA variants.
These variants were still able to bind CO and the UV-visible spectra of the CO-bound forms were similar to each other and to that of wild-type CO-bound CooA, with minor variations ( Fig. 2A and Table II ). This suggests that there is not a dramatic effect on the local heme environment in these forms. When CO was added to the imidazole adducts of the above CooA variants, the spectra of the resultant forms were indistinguishable from their CO-bound forms in the absence of imidazole (data not shown), indicating that CO can completely displace the imidazole ligand under these conditions. DNA-binding abilities of the proteins were then measured using the method of fluorescence polarization to quantify the effectiveness of imidazole in inducing the active conformation. Fig. 2B shows the titration of selected imidazole-responsive variants to target DNA under three conditions: no effector, 50 mM imidazole, and 20% CO (v/v). Although the selected imidazole-responsive variants differ in the degree of imidazole responsiveness, they are all dramatically better than wild-type or ⌬P3R4 CooA, which showed no DNA binding in response to imidazole up to 1 M protein ( Fig. 2B and Table III ). In response to CO, all these variants showed poorer DNA binding than did wild type CooA, and a Trp at position 116 was particularly detrimental (Fig. 2B and Table III) , consistent with the in vivo data (Table I) and previous results (8) . Importantly, however, some of the variants were significantly poorer at responding to CO than to imidazole. Similar results were seen when CO was added to the pre-existing imidazole adducts of these variants (data not shown). In the absence of any effector, none of the variants had significant DNA-binding activity (Fig. 2B) . Table III summarizes DNA-binding characteristics of these variants in response to either imidazole or CO and compares their ligand responsiveness with that of wild-type CooA.
⌬P3R4/Arg
113 /Trp 116 CooA displayed the best DNA affinity in response to imidazole, as well as the greatest change in ligand specificity, where it showed a change of specificity of ϳ3000-fold relative to wild-type CooA (Table III) . Taken together, these results strongly argue that imidazole ligation to the heme iron initiates the activation of these variants. It is also clear that the effector specificity has not merely been expanded, but rather has been dramatically altered, such that some variants respond better to imidazole than to CO.
As explained in the introduction, the ability of these proteins to bind DNA results from a repositioning of the DNA-binding domains, which in wild-type CooA involves movement of the C helices. Because the residue changes in these variants lie far from the DNA-binding domains themselves, it is highly likely that they also reposition their C helices in the course of becoming active, rather than create a completely different signal pathway. It is therefore interesting that there is no clear correlation between imidazole responsiveness and CO responsiveness among these variants. This result implies that these variants sense the two effectors by rather different specific mechanisms. It is also apparent that the major contribution to the change of ligand specificity is from increased DNA-binding ability in response to imidazole, rather than from perturbed DNA-binding ability in response to CO. (Fig. 3A) , 1-and 4-methylimidazole bound to the hemes at the tested level of 50 mM. 2-Methylimidazole did not bind as a heme ligand but perturbed the heme stability of the protein by an unknown mechanism. Neither 1-nor 4-methylimidazole perturbed the DNA-binding activity of CO-bound wild-type CooA at the tested level of 50 mM (data not shown), so any effect on the DNA-binding activities of the variants must be from the ligation property of these two molecules. At the saturating concentration (50 mM each) for heme ligation, imidazole and these two derivatives produced meaningfully different responses with the variants in terms of DNA binding (Fig.   3B ). In the case of ⌬P3R4/Arg 113 /Trp 116 , imidazole was far more effective than the two derivatives. In the case of ⌬P3R4/ Trp 113 /Phe 116 , imidazole was more effective than 4-methylimidazole, which was itself more effective than 1-methylimidazole. Surprisingly, in the case of ⌬P3R4/Trp 113 /Leu 116 , 4-methylimidazole was more effective than imidazole or 1-methylimidazole. Although we cannot propose the specific nature of these interactions, these results show that differences in residues at 113 and 116 have marked effects on the ability of the protein to interact with target DNA because of differences in the recognition of each heme-bound imidazole molecule. This implies that these CooA variants sense and respond to imidazole and its derivatives by specific interactions, which are presumably steric. Our working hypothesis is that these direct imidazole-113/116-residue interactions promote the C-helix repositioning that results in a DNA-binding form of CooA. Presumably those combinations of imidazole derivative and variant that are less (Fig. 4A) , consistent with a five-coordinate NO-bound form (7) . Despite this clear ligand binding, however, this variant showed no DNA binding in response to either small molecule up to a 1 M protein concentration (Fig. 4B) Because we do not know the structure of the active form of CooA, we can only speculate on the inability of CN Ϫ and NO to induce that conformational change. As noted earlier, however, the critical requirement for the C-helix residues in the response of wild-type CooA to CO is that they must be hydrophobic (8) . This had led to the hypothesis that hydrophobicity of the ligand-bound heme and heme pocket is necessary for the heme to position itself near the C helices to support activation of the protein (8) . The lack of response of the imidazole-responsive variants to CN Ϫ indicates that the production of six-coordinate heme is not enough for the activation of the variant proteins, and the above hypothesis continues to be valid in the variant proteins. In contrast, NO displaces both protein ligands in the imidazole-responsive variants, as it does in wild-type CooA, which it also fails to activate (7). In wild-type CooA, His 77 , the protein ligand in CO-bound form, is absolutely critical for COsensing function (Ref. 17 and see below). Thus, the inability of NO to induce activation of the imidazole-responsive variants suggests that retention of the His 77 tethering might be important for the response to other effectors as well.
The Imidazole Recognition Mechanism in Imidazole-responsive CooA Variants Is Locally Distinct from the CO Recognition
Mechanism in Wild-type CooA-The identification of imidazoleresponsive variants generated through changes at positions 113 and 116 initially surprised us, because the amino acid requirements at these positions were not very restrictive for a substantial response to CO by either wild-type CooA (8) or ⌬P3R4 CooA (Table IV) . In each case we had randomized these codons, selected variants that were CO-responsive, and sequenced a number of clones. The result was that a variety of amino acids provided significant CO responsiveness, although there was a requirement for hydrophobic residues. This is in contrast to the requirement of rather specific residues at those positions for imidazole responsiveness in the imidazole-responsive variants. This paradox led us to the hypothesis that there must be a different local recognition mechanism in the imidazole-responsive CooA variants in response to imidazole than in wild-type CooA to CO. To investigate the difference between the two mechanisms, we moved a couple of other substitutions into an imidazole-responsive background, where these substi- tutions had already been shown to have an impact on CO responsiveness in wild-type CooA. The first change was H77A, which removes the normal heme ligand in Fe(II) and CO-bound forms of CooA (His 77 is indicated in Fig. 1) , and destroyed CO response in wild-type CooA (17) (Fig. 5A) . This substitution had a comparable effect on imidazole responsiveness (Fig. 5B) , which suggests that His 77 is the protein ligand in the CooA-imidazole adduct in ⌬P3R4/Trp 113 / Trp 116 , and an approximately normal heme position is critical for response to both effectors in the appropriate proteins.
The second substitution, I95W, affects a residue near the heme (Ile 95 is indicated in Fig. 1 ). This substitution apparently causes a steric effect on the heme positioning that enhances the CO-dependent activity of many poorly active CooA variants (8) and has a modest effect on wild-type CooA (Fig. 5A) . However, this substitution causes a dramatic loss in imidazole responsiveness of ⌬P3R4/Trp 113 /Trp 116 (Fig. 5B) , implying that the heme position suitable for activation is different for the two effectors. The effect of I95W on ⌬P3R4/Trp 113 /Phe 116 CooA was also examined, because this CooA variant showed a roughly similar response to both CO and imidazole (Table I ). The I95W substitution dramatically decreased imidazole responsiveness of this variant but significantly increased its CO responsiveness (Fig. 5C) For the generation of CN Ϫ -bound and NO-bound forms, each ligand was added to Fe(III) forms before reduction with sodium dithionite to 2 mM. 50 mM KCN and 20% NO (v/v) were used, respectively. In A, the abrupt absorbance increase below 380 nm is due to 2 mM dithionite. In B, imidazole-responsive activity of the protein was also included for visual comparison.
deed, we had randomized the C-helix residues in a ⌬P3R4 background for exactly this reason. CooA proteins and examined their imidazole responses. As expected, their in vivo imidazole-responsive activities were significantly reduced compared with variants with the ⌬P3R4 substitutions, and the degree of imidazole selectivity was diminished, but they still displayed a surprising level of imidazole responsiveness (Fig.  6) . We interpret this to mean that Pro 2 continues to be an important aspect of ligand selectivity in CooA, but not a critical one, because it can be overcome by the C-helix changes that allow functional imidazole binding. Because repositioning of the C-helices is critical for CooA activation (14) , it is our hypothesis that the Trp-imidazole interaction stimulates that repositioning, albeit by a different mechanism than used by wild-type CooA for CO.
Gly-117 and Leu-120 Are Critical for Response to Both CO and Imidazole and Therefore Do Not Provide the Basis for CO Specificity in Wild-type CooA-The response of the appropriate variants to imidazole clearly involves a very specific interaction with certain C-helix residues and we had initially assumed that a similar set of specific contacts might be involved in the specificity of wild-type CooA to CO. However, a variety of residues at positions 113 and 116 provided reasonably good response to CO, eliminating these residues as candidates (8) . Gly 117 and Leu 120 were attractive possibilities, because they were critical for a proper response to CO (16), 2 as well as being near the bound CO (15) . However, when the very conservative G117A and L120I substitutions were placed in an imidazoleresponsive variant background, the response to imidazole was also reduced (Fig. 5B) . As a further test, we randomized each position separately in the ⌬P3R4/Trp 113 /Trp 116 background and screened for imidazole-responsive variants. Such variants were present at a few percent of the population and four sequenced clones in each case encoded Gly 117 and Leu 120 , respectively (data not shown). This result strongly suggests that Gly 117 and Leu 120 are essential for proper imidazole-sensing function of the variant, and those amino acids cannot be replaced for that function. The fact that the same residues were optimal for the response to both CO and imidazole strongly argues against their serving only a specific role in recognition of CO in wild-type CooA. Although it is possible that these residues play dissimilar roles for each effector, it is simpler to propose that their roles are in some way related to the C-helix repositioning that must take place in response to each effector. This result has the further important implication that there is no longer any obvious candidate residue for making specific contacts with the effector, CO.
DISCUSSION
Working Hypothesis for Imidazole-sensing Mechanism-The ability of some CooA variants to bind DNA in response to imidazole and its derivatives certainly means that some fraction of the protein population has positioned its DNA-binding domains to interact with specific DNA sequence. It is our working hypothesis that this active population arises because there has been a repositioning of the C helices upon imidazole binding, based on the following arguments: (i) Such C-helix repositioning is necessary and sufficient to create DNA-binding activity in both wild-type CooA and other variants (14) . (ii) The imidazole-bound heme and residues 113 and 116 are far from the DNA-binding domains, so they are unlikely to reposition those domains by a completely novel mechanism bypassing the C helix. (iii) The importance of Gly 117 and Leu 120 for responsiveness to both imidazole and CO also implies a common C-helix signaling pathway. (iv) The results with imidazole derivatives strongly argue that there is specific contact between the heme-bound imidazole and specific C-helix residues, providing an obvious opportunity for the repositioning of the helices. What might be the basis for this mechanism?
The requirement for a Trp residue for an imidazole response implies a specific interaction between imidazole and Trp, although there is clearly some flexibility in this, because Trp at either position 113 or 116 works reasonably well. However, the precision of these interactions is revealed by the differential responses to different imidazole derivatives. Although we cannot propose a molecular description of the precise conformations, the effects of single methyl groups imply that the interactions are steric rather than electronic. Because specific interactions are clearly necessary, we assume that these serve to draw the C helices to a position that roughly mimics that created by CO in wild-type CooA. Poor DNA affinity of some C-helix variants in response to specific effectors presumably reflects either incomplete or improper C-helix repositioning, leading to a smaller population of DNA-binding CooA. This differential repositioning certainly must reflect subtle differ-2 R. L. Kerby, unpublished results. ences in effector-protein interaction. We believe that the imidazole-responsive variants employ a mechanism that is locally distinct from that of wild-type CooA in response to CO to achieve C-helix repositioning. This view is supported by the opposite effects of the I95W substitution on the responsiveness of the same CooA variants to CO and imidazole.
The idea of C-helix repositioning arising by dissimilar mechanisms is further supported by results with at least one previously reported CooA variant. L116K CooA has a remarkable property in that it is active when reduced but loses activity upon CO binding (24) . This has been explained by the presence of a new heme ligand in the Fe(II) form, the introduced Lys 116 , which itself causes C-helix repositioning. The binding of CO necessarily disrupts that interaction by replacing the new ligand (and the poor activity of the CO-bound form presumably reflects the fact that it no longer has a hydrophobic heme pocket necessary for a response to CO, as discussed below). Taken together, the results imply that there are a variety of local mechanisms that can position the C-helix signaling pathway with differing degrees of precision.
Implications for CO-sensing Mechanism of Wild-type CooAOur working hypothesis for the CO activation of CooA has been the following (8) : (i) CO has the proper ligand strength and size to replace the Pro 2 residue. (ii) This releases the N terminus, which leaves the vicinity of the bound CO (12, 15) and exposes the hydrophobic C-helix residues to solvent. (iii) In response, the C-helices reposition themselves, and this repositioning is transmitted to the DNA-binding domains through C-helix rigidity. As discussed below, two important questions in this process have been addressed by the present data: What provides the specificity for CO in wild-type CooA, and how does CO binding to the heme induce the conformational change that leads to DNA binding?
In contrast to the case with imidazole, we now have no evidence that there is specific contact between the bound CO and a certain residue of CooA. For example, a maximum response to both CO and imidazole depends on Gly at position 117. This result does not disprove Gly 117 as a CO contact, but it is simpler to suppose that it serves a similar role in response to both effectors, which would obviate a CO-specific role. Similarly, hydrophobic residues at positions 116 and 120 are critical for response to CO. Presumably they contribute to the hydrophobic heme pocket and likely function in C-helix interactions, given their "d" and "a" positions along the C-helix coiled-coil motif. Finally, position 113 shows a wider range of acceptable residues for the CO-response, eliminating it as a specific contact. If there is no specific contact, what is the basis for the specificity of CO-sensing? The data with I95W strongly implies that the position of the heme is important for a response to CO binding, although that positioning is certainly different from that seen with imidazole in the appropriate variants. This implies that CO is sensed by the proper position of the heme, and that CooA essentially recognizes two heme positions: the heme-Pro 2 moiety in the "off" state and the heme-CO moiety in the "on" state.
We therefore believe that CO binding allows the heme to move into a position different from that of Fe(II) CooA and this new position is compatible with the global active conformation of the CooA protein. We imagine two possible roles of CO for this heme repositioning. First, CO binding allows the hydrophobic interaction between the CO-bound heme and the hydrophobic C-helix residues, which results in a new heme position. It is even possible that CO is making important contacts with the backbone of the C helices, because such an interaction would be missed in our analysis of variants. Second, CO binding has a strong trans effect on the Fe-His 77 bond, as shown by the marked perturbation of this bond through resonance Raman spectroscopy (15, 26) . Perturbation of this bond would necessarily affect the heme position, which in turn would affect the C helices. The CO specificity in wild-type CooA is therefore the result of a combination of size, ligand strength, and absence of charge of the effector that probably affect heme positioning through direct effects on both the distal and proximal sides of the heme.
Implications of the Results for Other Heme-based Sensors-⌬P3R4/Trp
113 /Phe 116 CooA, a variant created in this study, responds to both CO and imidazole, yet it is clear from the effect of the I95W substitution that it does so by distinct mechanisms. The notion of distinct sensing mechanisms providing a roughly similar response is also a clear conclusion from the requirement for specific C helix residues for maximal response to different imidazole derivatives. This is in contrast to the more generalized dependence for hydrophobic residues for CO response. Such an idea is also consistent with the observation that soluble guanylyl cyclase can respond to both NO and CO, but again by distinct mechanisms. In this protein, NO has been shown to trigger a conformational change through the cleavage of the proximal histidine ligand, His 105 , which results in a five-coordinate high spin heme adduct (27) . CO binding provides lower, but still substantial, levels of activity in vitro (28) , but creates a six-coordinate low spin heme adduct with an intact His-iron bond (29) , suggesting that the activation mechanism of CO must be different from that of NO. This conclusion might be premature, however, with the recent suggestion of a five-coordinate adduct in response to CO binding (30) .
Though FixL shows substantial selectivity in responding to O 2 , it does respond to other small molecules, and the literature has the underlying assumption that the activation by these different molecules involves a fundamentally similar mechanism. In other words, the extent of FixL activation in response to an effector corresponds to the relative efficiency with which that effector induces a specific local conformational change. Two different models have been suggested for this common activation mechanism: a spin-state change (31) or an interaction between a specific Arg residue and the heme propionate (32) . The results reported here with CooA, however, suggest that this assumption of a single activation mechanism might not be a valid one. The general conclusion is simply that an understanding of the selectivity of heme-based sensors will require a detailed understanding of the proteins' response to the effector-bound heme and not merely an analysis of the immediate heme environment.
Conclusion-We have demonstrated the successful allosteric-level engineering of a CO-specific heme protein into an imidazole-responsive one and even one that discriminates among imidazole derivatives. Part of the molecular basis for imidazole responsiveness in the CooA variants involves the direct recognition of imidazole as a ligand, which is clearly quite distinct from the CO-sensing mechanism of wild-type CooA. Nevertheless, the identical requirement for other residues known to be critical for the response of wild-type CooA to CO implies that the conformational response to imidazole binding is substantially similar to the response of wild-type CooA to CO. The results therefore provide further information on the CO response of wild-type CooA: (i) Two distinct levels of CO discrimination are clearly revealed: Pro 2 ligation and some critical feature of the CO-bound heme. (ii) The obvious candidate residues for that latter level of discrimination have either been ruled out, or at least the supporting data have been given a more plausible explanation. This result has suggested a rather different model for specificity based on the unique ability of CO to allow the heme to move to a position that supports C-helix repositioning. We currently believe that the specificity of CooA for CO largely results from its ligand strength, small size, and absence of charge (which copes well with hydrophobic distal heme pocket of the protein), although an additional role on the trans Fe-His 77 ligation is also attractive. Models involving electrostatic interactions between CO and protein residues (33) appear rather less attractive, because the CO pocket of CooA is hydrophobic (13, 15) . (iii) The notion of C-helix repositioning as a critical aspect of CooA response to effectors has been extended to imidazole. This suggests that it might be a general mechanism for effector response among the large cAMP receptor protein/FNR fumarate and nitrate reductase activator protein family of proteins. Similarly, the importance of proper heme positioning for a response to CO has been supported by the non-identical but related heme-positioning requirement for a response to imidazole.
